Efficacy of Dapagliflozin in Adult Autosomal Recessive Alport Syndrome.

Kidney Int Rep · 2022 · PMC9459024 · PMID 36090488

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

With a follow-up of 4 to 6 months, proteinuria showed a decreasing trend in all the 3 cases of autosomal recessive Alport syndrome, with 24-hour proteinuria decreasing by 0.17 g/24h (8.9%), 0.61 g/24h (39.9%), and 0.69 g/24h (52.3%) respectively ( Figure 1 ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.